TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-0.27%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.92B
AUM Growth
+$75.1M
(+2%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,030
Increased
2,258
Reduced
2,500
Closed
686
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$333M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$80.8M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$42.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$39.6M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$26M |
Top Sells
| 1 |
iShares Semiconductor ETF
SOXX
|
+$19M |
| 2 |
UnitedHealth
UNH
|
+$18.7M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$17.7M |
| 4 |
Salesforce
CRM
|
+$17.2M |
| 5 |
Tesla
TSLA
|
+$16.2M |
Sector Composition
| 1 | Technology | 18.51% |
| 2 | Consumer Discretionary | 8.04% |
| 3 | Healthcare | 7.14% |
| 4 | Communication Services | 6.4% |
| 5 | Financials | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Everspin Technologies
MRAM
$176M
| $10K | ﹤0.01% |
1,535
+1,140
| +289% | +$7.43K |
|
4327
National CineMedia
NCMI
$458M
| $10K | ﹤0.01% |
292
-1,362
| -82% | -$46.6K |
|
4328
NCS Multistage Holdings
NCSM
$124M
| $10K | ﹤0.01% |
334
-113
| -25% | -$3.38K |
|
4329
NRX Pharmaceuticals
NRXP
$70.8M
| $10K | ﹤0.01% |
103
+90
| +692% | +$8.74K |
|
4330
Palo Alto Networks
PANW
$135B
| $10K | ﹤0.01% |
126
-3,492
| -97% | -$277K |
|
4331
Provident Bancorp
PVBC
$226M
| $10K | ﹤0.01% |
619
-287
| -32% | -$4.64K |
|
4332
Red Violet
RDVT
$699M
| $10K | ﹤0.01% |
383
-188
| -33% | -$4.91K |
|
4333
Riley Exploration Permian
REPX
$618M
| $10K | ﹤0.01% |
428
+207
| +94% | +$4.84K |
|
4334
The ONE Group
STKS
$79.9M
| $10K | ﹤0.01% |
981
-2,018
| -67% | -$20.6K |
|
4335
Taoping
TAOP
$4.09M
| $10K | ﹤0.01% |
+12
| New | +$10K |
|
4336
Tarsus Pharmaceuticals
TARS
$2.14B
| $10K | ﹤0.01% |
465
-708
| -60% | -$15.2K |
|
4337
Tenaya Therapeutics
TNYA
$205M
| $10K | ﹤0.01% |
+479
| New | +$10K |
|
4338
Tourmaline Bio
TRML
$1.23B
| $10K | ﹤0.01% |
79
+73
| +1,217% | +$9.24K |
|
|
URG
4339
Ur-Energy
URG
$547M
| $10K | ﹤0.01% |
5,770
-20,583
| -78% | -$35.7K |
|
4340
UroGen Pharma
URGN
$836M
| $10K | ﹤0.01% |
600
-2,694
| -82% | -$44.9K |
|
4341
United States Lime & Minerals
USLM
$3.7B
| $10K | ﹤0.01% |
410
-285
| -41% | -$6.95K |
|
4342
Reaves Utility Income Fund
UTG
$3.4B
| $10K | ﹤0.01% |
+305
| New | +$10K |
|
4343
Vera Therapeutics
VERA
$1.58B
| $10K | ﹤0.01% |
+605
| New | +$10K |
|
4344
Vanguard FTSE Europe ETF
VGK
$27.3B
| $10K | ﹤0.01% |
142
-15,570
| -99% | -$1.1M |
|
4345
Verrica Pharmaceuticals
VRCA
$41.7M
| $10K | ﹤0.01% |
77
-159
| -67% | -$20.6K |
|
|
VRNA
4346
Verona Pharma
VRNA
$9.19B
| $10K | ﹤0.01% |
1,777
+412
| +30% | +$2.32K |
|
4347
XBiotech
XBIT
$82M
| $10K | ﹤0.01% |
800
-704
| -47% | -$8.8K |
|
4348
Xponential Fitness
XPOF
$295M
| $10K | ﹤0.01% |
+804
| New | +$10K |
|
|
NIXX
4349
Nixxy, Inc. Common Stock
NIXX
$38.5M
| $10K | ﹤0.01% |
+190
| New | +$10K |
|
|
OKUR
4350
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$32.1M
| $10K | ﹤0.01% |
130
+126
| +3,150% | +$9.69K |
|